27090298|t|Circulating Fatty Acid Synthase in pregnant women: Relationship to blood pressure, maternal metabolism and newborn parameters.
27090298|a|The enzyme FASN (fatty acid synthase) is potentially related with hypertension and metabolic dysfunction. FASN is highly expressed in the human placenta. We aimed to investigate the relationship circulating FASN has with blood pressure, maternal metabolism and newborn parameters in healthy pregnant women. Circulating FASN was assessed in 115 asymptomatic pregnant women in the second trimester of gestation along with C-peptide, fasting glucose and insulin, post-load glucose lipids, HMW-adiponectin and blood pressure (the latter was assessed in each trimester of gestation). At birth, newborns and placentas were weighed. FASN expression was also able to be assessed in 80 placentas. Higher circulating FASN was associated with lower systolic blood pressure (SBP), with a more favourable metabolic phenotype (lower fasting glucose and insulin, post load glucose, HbAc1, HOMA-IR and C-peptide), and with lower placental and birth weight (all p < 0.05 to p < 0.001). Placental FASN expression related positively to circulating FASN (p < 0.005) and negatively to placental weight (p < 0.05). Our observations suggest a physiological role of placental FASN in human pregnancy. Future studies will clarify whether circulating FASN of placental origin does actually regulate placental and fetal growth, and (thereby) has a favourable influence on the pregnant mother's insulin sensitivity and blood pressure.
27090298	12	31	Fatty Acid Synthase	GeneOrGeneProduct	2194
27090298	44	49	women	OrganismTaxon	9606
27090298	138	142	FASN	GeneOrGeneProduct	2194
27090298	144	163	fatty acid synthase	GeneOrGeneProduct	2194
27090298	193	205	hypertension	DiseaseOrPhenotypicFeature	D006973
27090298	210	231	metabolic dysfunction	DiseaseOrPhenotypicFeature	D008659
27090298	233	237	FASN	GeneOrGeneProduct	2194
27090298	265	270	human	OrganismTaxon	9606
27090298	334	338	FASN	GeneOrGeneProduct	2194
27090298	427	432	women	OrganismTaxon	9606
27090298	446	450	FASN	GeneOrGeneProduct	2194
27090298	493	498	women	OrganismTaxon	9606
27090298	547	556	C-peptide	ChemicalEntity	D002096
27090298	566	573	glucose	ChemicalEntity	D005947
27090298	578	585	insulin	GeneOrGeneProduct	3630
27090298	597	604	glucose	ChemicalEntity	D005947
27090298	605	611	lipids	ChemicalEntity	D008055
27090298	613	616	HMW	GeneOrGeneProduct	57587
27090298	617	628	adiponectin	GeneOrGeneProduct	9370
27090298	753	757	FASN	GeneOrGeneProduct	2194
27090298	834	838	FASN	GeneOrGeneProduct	2194
27090298	954	961	glucose	ChemicalEntity	D005947
27090298	966	973	insulin	GeneOrGeneProduct	3630
27090298	985	992	glucose	ChemicalEntity	D005947
27090298	994	999	HbAc1	GeneOrGeneProduct	3043
27090298	1013	1022	C-peptide	ChemicalEntity	D002096
27090298	1106	1110	FASN	GeneOrGeneProduct	2194
27090298	1156	1160	FASN	GeneOrGeneProduct	2194
27090298	1279	1283	FASN	GeneOrGeneProduct	2194
27090298	1287	1292	human	OrganismTaxon	9606
27090298	1352	1356	FASN	GeneOrGeneProduct	2194
27090298	1494	1501	insulin	GeneOrGeneProduct	3630
27090298	Association	2194	D008659	No
27090298	Association	2194	D006973	No
27090298	Negative_Correlation	2194	D002096	Novel
27090298	Negative_Correlation	2194	3043	Novel
27090298	Negative_Correlation	2194	3630	Novel
27090298	Negative_Correlation	2194	D005947	Novel
27090298	Association	57587	9370	No